How Fauci's Wife Used NIH Position To Backstop Her Husband’s Pandemic Health Directives Authored by Adam Andrzejewski via OpenTheBooks, It's...
Viruses, including SARS-CoV-2, use an extensive arsenal to help them cleverly evade the immune system, proliferate and cause disease. Among their formidable...
Sherlock says the technology has shown in tests the potential to deliver flexible, high-accuracy, low-cost Cas12-based detection of diseases, including...
9 Things You Need To Know About Paxlovid Authored by Dr. Yuhong Dong via The Epoch Times (emphasis ours), Do you know when Paxlovid should...
Growing Number Of Doctors Say They Won’t Get COVID-19 Booster Shots Authored by Zachary Stieber via The Epoch Times (emphasis ours), A...
Some things that come in threes are seen in a positive light. But threes also have their dark side, as evidenced by the so-called tripledemic—the unprecedented...
Two announcements occurred this week, both of note and connected only by the fact that they are emblematic of the slow metamorphosis from a COVID emergency...
While mRNA took center stage at yesterday’s FDA vaccine advisory committee meeting, Novavax announced its plans to deliver an updated protein-based vaccine...
Pentagon "Exploring" Back-Pay For Troops Kicked Out Over COVID Vaccine Mandate Authored by Jack Phillips via The Epoch Times, The U.S. Department...
How Can We Trust Institutions That Lied? Authored by Abir Ballan via The Brownstone Institute, Trust the Authorities, trust the Experts,...
'Normalization' Of Emergency Use Authorizations Concerns Health Experts Authored by Marina Zhang via The Epoch Times (emphasis ours), The...
FDA Deviated From Normal Process In Pfizer Vaccine Approval, Documents Show Authored by Zachary Stieber via The Epoch Times (emphasis ours), U.S....
This Censorious Pfizer Board Member Was A Major Influence On Lockdowns Authored by Jeffrey A. Tucker via the Brownstone Institute (emphasis...
Robinhood stocks under $5 to watch this week. The post 3 Cheap Stocks On Robinhood To Buy For Under $5 appeared first on Penny Stocks to...
The year’s crop of US drug approvals won’t rival past vintages for quantity. But of the 45 drugs cleared for use by the FDA in 2022,...
In War For Control Of Humanity, Thoughts And Emotions Are The Battlefield: Dr. Robert Malone Authored by Masooma Haq and Jan Jekielek via...
Jim Quinn: It's Not A Lie If You Believe It Authored by Jim Quinn via The Burning Platform blog, “The past was erased, the erasure was...
FDA Approves Monoclonal Antibody To Treat COVID-19 For First Time Authored by Mimi Nguyen Ly via The Epoch Times (emphasis ours), The U.S....
Roche upgraded its emergency use authorization for Actemra in certain hospitalized Covid-19 patients to a full FDA approval, the company announced Wednesday,...
MUSC Hollings Cancer Center oncologists found that using a combination monoclonal antibody (tixagevimab-cilgavimab) against the SARS-CoV-2 spike protein...
The Truth About Ivermectin Authored by Marina Zheng via The Epoch Times (emphasis ours), Ivermectin has been hailed as a “wonder drug”...
COLUMBIA, Mo. – Monkeypox has infected more than 77,000 people in more than 100 countries worldwide, and — similar to COVID-19 — mutations have enabled...
Military Whistleblowers Sound Alarm On 'Devastating' Consequences Of Pentagon’s Vaccine Mandate Authored by J.M. Phelps via The Epoch Times...
Pfizer Plans To Hike Price Of US COVID-19 Vaccine By 400% Authored by Naveen Anthrapully via The Epoch Times, Pfizer is looking to raise...
The United States Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA), which was immediately endorsed by the U.S. Centers for...
The pharmaceutical giant, still riding high on the sales of Comirnaty and Paxlovid, is looking to a future of innovative oncology drugs and vaccines based...
2022 has been marked by the first year of leadership under CEO Joaquin Duato and the anticipated separation of the company’s consumer health busines...
Targeted business development acquisitions, improvements in R&D and operating performance, and a strengthened post-demerger balance sheet are creating...
It might seem like luck for a company to trip over a multi-billion dollar COVID treatment already lurking in its pipeline – but perhaps not so...
A strong product pipeline and increased group sales confirm that Roche is on the right growth path.